Welcome to our dedicated page for Confluent SEC filings (Ticker: CFLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Confluent, Inc. (NASDAQ: CFLT) files reports and disclosures with the U.S. Securities and Exchange Commission (SEC) in connection with its listing on the Nasdaq Global Select Market and its status as a public company. These filings provide detailed information on its data streaming business, financial condition, and significant corporate events.
Among the key documents for CFLT are Form 10-K annual reports and Form 10-Q quarterly reports, which describe Confluent’s operations as a data streaming platform provider, outline its revenue from subscriptions and services, and discuss risks and other disclosures. Investors often review these filings to understand how Confluent presents its business model, including offerings such as Confluent Cloud, Confluent Platform, WarpStream, Confluent Private Cloud, Confluent Intelligence, Streaming Agents, Real-Time Context Engine, and Tableflow.
Confluent also uses Form 8-K current reports to disclose material events. For example, a Form 8-K dated December 8, 2025 describes an Agreement and Plan of Merger with International Business Machines Corporation (IBM) and a wholly owned IBM subsidiary. That filing outlines the proposed merger structure, the cash consideration for shares, the treatment of equity awards, closing conditions, termination rights, and potential termination fees. Other 8-K filings referenced in the available data report the release of quarterly financial results.
On this SEC filings page, users can access Confluent’s historical and ongoing disclosures, including 10-K, 10-Q, and 8-K filings, as well as proxy materials related to the IBM transaction once filed. The platform also surfaces Form 4 insider transaction reports and other ownership-related filings when available, allowing investors to monitor changes in holdings by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, highlight major risk factors, and clarify complex transaction terms. Real-time updates from the SEC’s EDGAR system help ensure that new CFLT filings, including those related to the pending IBM merger, are quickly available with plain-language explanations.
Confluent, Inc. Chief Accounting Officer Phan Kong reported an open-market sale of Class A common stock mainly to cover taxes tied to a restricted stock unit vesting. The transaction involved 2,277 shares at a weighted-average price of $30.70 per share. After this sale, Kong directly owns 218,228 shares of Confluent Class A common stock, indicating the sale was small relative to his remaining stake.
Confluent, Inc. CEO Edward Jay Kreps reported a combination of share conversions and sales. He converted 232,500 shares of Class B Common Stock into 232,500 shares of Class A Common Stock through a derivative security conversion at a stated price of $0.00 per share, bringing his direct Class B holdings to 14,017,500 shares.
On the same date, he sold 270,207 shares of Class A Common Stock in open-market transactions at a price of $30.70 per share, executed under a Rule 10b5-1 trading plan adopted on August 15, 2024. After these sales, his direct Class A holdings were 301,660 shares. Additional Class B shares are held indirectly through family trusts.
CFLT notice of proposed sale: 19,756 restricted stock units are identified for sale in a Form 144 filing. The filing also lists recent 10b5-1 sales by an affiliate, including 44,114 shares sold on 12/08/2025 for $1,313,489.94.
Edward Kreps reports proposed sales of common stock under Rule 144. The filing lists Founders Shares: 232,500 (dated 09/27/2019) and Restricted Stock Units: 37,707 (dated 02/20/2026) as securities to be sold.
The filing also discloses recent 10b5-1 sales: 12/15/2025 — 232,500 shares for $6,997,459.50; 12/12/2025 — 506,000 shares for $15,200,240.00.
Confluent, Inc.’s Chief Revenue Officer, Ryan Mac Ban Norris, reported open-market sales of Class A common stock under a pre-arranged 10b5-1 trading plan dated August 22, 2025. He sold 1,655 shares at $30.54 on February 13, 2026 and 2,113 shares at $30.61 on February 18, 2026, totaling 3,768 shares.
After these transactions, he directly owned 390,163 shares of Confluent Class A common stock. This amount includes 1,398 shares acquired through the company’s employee stock purchase plan on February 13, 2026, indicating he retains a substantial equity position following the scheduled sales.
Confluent, Inc. director Michelangelo Volpi reported that the Volpi-Cupal Family Trust, with which he is associated as trustee, sold 25,000 shares of Class A common stock in an open‑market transaction. The shares were sold at an average price of about $30.59 per share under a Rule 10b5-1 trading plan dated June 13, 2025.
According to the disclosure, the sale prices ranged from $30.535 to $30.63 per share. After this transaction, the trust held 155,512 shares of Class A common stock, and Volpi also reported 235,041 shares held directly. The filing notes that he disclaims beneficial ownership of the trust’s shares except to the extent of any pecuniary interest.
Confluent, Inc. director Neha Narkhede reported a combination of option exercises, share conversions, and an open-market sale. She exercised stock options for 80,000 shares, which led to the conversion of 80,000 shares of Class B Common Stock into 80,000 shares of Class A Common Stock. She then sold 80,000 Class A shares at a price of $30.59 per share pursuant to a pre-established Rule 10b5-1 trading plan adopted on June 10, 2025. After these transactions, she held 28,549 shares of Class A Common Stock directly and 1,787 shares of Class A Common Stock indirectly through a trust, while retaining a substantial Class B stake and remaining option holdings.
Confluent, Inc. director Eric Vishria, through entities he controls, reported an open-market sale of 61,905 shares of Class A common stock on February 13, 2026 at an average price of $30.57 per share under a pre-arranged 10b5-1 trading plan. After this indirect sale, entities he controls held 663,637 shares, and he also reported 20,861 shares held directly.
CFLT-related Form 144: Proposed and recent insider sales reported by a broker and an individual. The filing lists two planned sales of common stock associated with an Employee Stock Purchase Plan on 02/13/2026 (1,398 shares) and 08/15/2025 (715 shares). It also lists multiple sales by Ryan Mac Ban during the preceding three months: 12/23/2025 3,053 shares for $91,470.93; 12/22/2025 1,218 shares for $36,487.75; 12/08/2025 44,114 shares for $1,313,273.78; and two trades on 11/20/2025 of 10,145 shares for $228,316.27 and 4,917 shares for $110,658.56.
Confluent, Inc. (CFLT) received an amended Schedule 13G filing from Point72 entities and Steven A. Cohen reporting beneficial ownership of 183,700 shares of Class A common stock, or 0.1% of the class, as of December 31, 2025.
The reported position represents shares issuable upon exercise of call options held by an investment fund managed by Point72 Asset Management, with voting and investment power shared among Point72 Asset Management, Point72 Capital Advisors, Inc., and Cohen. The filers state they directly own no Confluent Class A shares and disclaim being beneficial owners for certain legal purposes.
They also certify the securities were not acquired, and are not held, to change or influence control of Confluent, indicating a passive investment-style filing rather than an activist position.